TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma

被引:36
作者
Sang, Yi [1 ,2 ]
Chen, Ming-yuan [1 ]
Luo, Donghua [1 ]
Zhang, Ru-Hua [1 ]
Wang, Li [1 ]
Li, Mei [1 ]
Luo, Rongzhen [1 ]
Qian, Chao-Nan [1 ]
Shao, Jian-Yong [1 ]
Zeng, Yi-Xin [1 ]
Kang, Tiebang [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 3, Nanchang Key Lab Canc Pathogenesis & Translat Res, Nanchang, Peoples R China
关键词
nasopharyngeal carcinoma; metastasis; TEL2; SERPINE1; PLASMINOGEN-ACTIVATOR INHIBITOR-1; EPITHELIAL-MESENCHYMAL TRANSITION; ETS TRANSCRIPTION FACTOR; BREAST-CANCER; TUMOR-SUPPRESSOR; PAI-1; EXPRESSION; RADIOTHERAPY; BINDING; SNAIL; P53;
D O I
10.18632/oncotarget.5074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC). However, the molecular mechanisms of NPC metastasis are poorly understood. Here, using our customized gene microarray containing all of the known human transcription factors and the current markers for epithelial-mesenchymal transition, we report that TEL2 was down-regulated in highly metastatic NPC cells and the metastatic tissues in lymph node. Mechanistically, TEL2 inhibits the cell migration and invasion in vitro and metastasis in vivo by releasing its direct suppression on the SERPINE1 promoter in NPC. Consistently, an inverse correlation was observed between the protein levels of TEL2 and SERPINE1 using clinical NPC samples. Collectively, we have provided the first evidence that TEL2 plays a key role in NPC metastasis by directly down-regulating SERPINE1, and that this novel axis of TEL2 / SERPINE1 may be valuable to develop new strategies for treating NPC patients with metastasis.
引用
收藏
页码:29240 / 29253
页数:14
相关论文
共 39 条
  • [1] DISTANT METASTASES OF NASOPHARYNGEAL CARCINOMA - A STUDY OF 256 MALE-PATIENTS
    AHMAD, A
    STEFANI, S
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1986, 33 (03) : 194 - 197
  • [2] PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN URINARY-TRACT CANCER
    BASHAR, H
    URANO, T
    FUKUTA, K
    PIETRASZEK, MH
    HATA, M
    SUZUKI, K
    KAWABE, K
    TAKADA, Y
    TAKADA, A
    [J]. UROLOGIA INTERNATIONALIS, 1994, 52 (01) : 4 - 8
  • [3] A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
    Bei, Jin-Xin
    Li, Yi
    Jia, Wei-Hua
    Feng, Bing-Jian
    Zhou, Gangqiao
    Chen, Li-Zhen
    Feng, Qi-Sheng
    Low, Hui-Qi
    Zhang, Hongxing
    He, Fuchu
    Tai, E. Shyong
    Kang, Tiebang
    Liu, Edison T.
    Liu, Jianjun
    Zeng, Yi-Xin
    [J]. NATURE GENETICS, 2010, 42 (07) : 599 - U173
  • [4] ATF2 - A transcription factor that elicits oncogenic or tumor suppressor activities
    Bhoumik, Anindita
    Ronai, Zeev
    [J]. CELL CYCLE, 2008, 7 (15) : 2341 - 2345
  • [5] The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis
    Cardone, M
    Kandilci, A
    Carella, C
    Nilsson, JA
    Brennan, JA
    Sirma, S
    Ozbek, U
    Boyd, K
    Cleveland, JL
    Grosveld, GC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (06) : 2395 - 2405
  • [6] The ETS factor TEL2 is a hematopoietic oncoprotein
    Carella, C
    Potter, M
    Bonten, J
    Rehg, JE
    Neale, G
    Grosveld, GC
    [J]. BLOOD, 2006, 107 (03) : 1124 - 1132
  • [7] Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
    Chakrabarti, Rumela
    Hwang, Julie
    Blanco, Mario Andres
    Wei, Yong
    Lukacisin, Martin
    Romano, Rose-Anne
    Smalley, Kirsten
    Liu, Song
    Yang, Qifeng
    Ibrahim, Toni
    Mercatali, Laura
    Amadori, Dino
    Haffty, Bruce G.
    Sinha, Satrajit
    Kang, Yibin
    [J]. NATURE CELL BIOLOGY, 2012, 14 (11) : 1212 - +
  • [8] Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
    Chen, Qiu-Yan
    Wen, Yue-Feng
    Guo, Ling
    Liu, Huai
    Huang, Pei-Yu
    Mo, Hao-Yuan
    Li, Ning-Wei
    Xiang, Yan-Qun
    Luo, Dong-Hua
    Qiu, Fang
    Sun, Rui
    Deng, Man-Quan
    Chen, Ming-Yuan
    Hua, Yi-Jun
    Guo, Xiang
    Cao, Ka-Jia
    Hong, Ming-Huang
    Qian, Chao-Nan
    Mai, Hai-Qiang
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (23): : 1761 - 1770
  • [9] Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481
  • [10] Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
    Dong, Chenfang
    Yuan, Tingting
    Wu, Yadi
    Wang, Yifan
    Fan, Teresa W. M.
    Miriyala, Sumitra
    Lin, Yiwei
    Yao, Jun
    Shi, Jian
    Kang, Tiebang
    Lorkiewicz, Pawel
    St Clair, Daret
    Hung, Mien-Chie
    Evers, B. Mark
    Zhou, Binhua P.
    [J]. CANCER CELL, 2013, 23 (03) : 316 - 331